A Houston-based pharmaceuticals company filed for Chapter 7 bankruptcy, and its leaders have either resigned or been terminated.
About three months after leaving her post as the FDA’s principal deputy commissioner, Namandjé Bumpus, Ph.D., has found a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback